UPC — Universe Pharmaceuticals INC
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1809616 ·
Last close
$4.80
Market Cap
$24.04M
52W High
$17.96
52W Low
$2.00
ADV30
230,893
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | — | — | — | — | 71,465,699 | 27,559,730 | 15,820,636 |
| Sep 2025 | — | — | — | — | 69,303,440 | 33,592,025 | 13,173,930 |
| Mar 2025 | — | — | — | — | 80,667,159 | 47,272,851 | 25,482,206 |
| Sep 2024 | — | — | — | — | 67,953,393 | 29,497,693 | 22,450,452 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-15,398,436
Inventory
$1,979,795
Receivables
$15,237,416
ST Investments
$1,490,203
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$17,742,008
EBITDA
$-1,610,281
Free Cash Flow
$-21,434,016
Enterprise Value
$-17,040,286
Total Cash
$29,049,932
Total Debt
$9,553,493
Shares Out
5,008,313
Trailing EPS
$-1.38
Book Value
$98.78
ROE
-3.5%
ROA
-1.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Sep 2025 | 17,858,732 | -2,915,919 | -3,672,055 | 69,303,440 | 13,173,930 | 56,129,510 | -5,052,319 |
| Sep 2024 | 23,024,458 | -8,019,840 | -8,727,298 | 67,953,393 | 22,450,452 | 45,502,941 | -9,506,683 |
| Sep 2023 | 32,308,735 | -3,966,101 | -6,581,024 | 41,724,482 | 13,754,329 | 27,970,153 | 1,116,775 |
| Sep 2022 | 40,143,151 | -7,019,444 | -7,909,638 | 59,539,875 | 13,097,552 | 46,442,323 | -1,301,555 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| PVCT | PROVECTUS BIOPHARMACEUTICALS, INC. | $24.04M | $0.06 | — |
| TXMD | TherapeuticsMD, Inc. | $24.19M | $2.09 | — |
| AYTU | AYTU BIOPHARMA, INC | $23.58M | $2.17 | — |
| COCP | Cocrystal Pharma, Inc. | $23.31M | $1.21 | — |
| NXTC | NextCure, Inc. | $23.25M | $5.08 | — |
News headlines (Yahoo Finance, 1h cache)
Universe Pharmaceuticals Shares Rise 22.6% Premarket With No New Catalyst Identified
2026-09-02 10:47 · Yahoo
UPC Stock Surges 288% After Hours — What’s Driving The Rally?
2026-06-26 22:04 · Yahoo
Universe Pharmaceuticals INC Announces Strategic Acquisition to Expand Pharmaceutical Patent Portfolio
2026-06-26 20:05 · Yahoo
Universe Pharmaceuticals INC Announces Effective Date of Dual-Class Share Structure
2026-02-11 21:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.